HAP Trading’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-58,000
| Closed | -$13.8K | – | 807 |
|
|
2024
Q2 | $13.8K | Sell |
58,000
-48,400
| -45% | -$6.22M | ﹤0.01% | 558 |
|
|
2024
Q1 | $621K | Buy |
+106,400
| New | +$13M | 0.07% | 165 |
|
|
2023
Q3 | – | Sell |
-24,600
| Closed | -$37K | – | 1257 |
|
|
2023
Q2 | $37K | Buy |
+24,600
| New | +$3.17M | 0.01% | 558 |
|
|
2023
Q1 | – | Sell |
-11,800
| Closed | -$151K | – | 1633 |
|
|
2022
Q4 | $151K | Buy |
+11,800
| New | +$1.37M | 0.02% | 517 |
|
|
2022
Q3 | – | Sell |
-12,700
| Closed | -$36K | – | 2054 |
|
|
2022
Q2 | $36K | Sell |
12,700
-6,500
| -34% | -$478K | ﹤0.01% | 1161 |
|
|
2022
Q1 | $64K | Sell |
19,200
-10,200
| -35% | -$781K | ﹤0.01% | 1182 |
|
|
2021
Q4 | $178K | Sell |
29,400
-3,800
| -11% | -$325K | ﹤0.01% | 1061 |
|
|
2021
Q3 | $230K | Buy |
33,200
+16,100
| +94% | +$1.24M | 0.01% | 979 |
|
|
2021
Q2 | $52K | Sell |
17,100
-20,100
| -54% | -$1.52M | ﹤0.01% | 1466 |
|
|
2021
Q1 | $83K | Buy |
37,200
+2,000
| +6% | +$185K | ﹤0.01% | 1018 |
|
|
2020
Q4 | $846K | Sell |
35,200
-5,400
| -13% | -$800K | 0.02% | 466 |
|
|
2020
Q3 | $228K | Sell |
40,600
-8,300
| -17% | -$1.26M | 0.01% | 598 |
|
|
2020
Q2 | $955K | Buy |
+48,900
| New | +$6.65M | 0.05% | 285 |
|
|
2020
Q1 | – | Sell |
-140,800
| Closed | -$1.53M | – | 1528 |
|
|
2019
Q4 | $1.53M | Buy |
140,800
+109,000
| +343% | +$11M | 0.08% | 154 |
|
|
2019
Q3 | $54K | Sell |
31,800
-112,700
| -78% | -$13.3M | ﹤0.01% | 719 |
|
|
2019
Q2 | $1.28M | Buy |
144,500
+47,200
| +49% | +$5.74M | 0.1% | 162 |
|
|
2019
Q1 | $220K | Buy |
97,300
+59,900
| +160% | +$7.7M | 0.02% | 430 |
|
|
2018
Q4 | $215K | Buy |
37,400
+2,000
| +6% | +$250K | 0.01% | 530 |
|
|
2018
Q3 | $896K | Sell |
35,400
-12,000
| -25% | -$1.64M | 0.06% | 228 |
|
|
2018
Q2 | $1.48M | Buy |
47,400
+6,700
| +16% | +$632K | 0.07% | 190 |
|
|
2018
Q1 | $277K | Buy |
40,700
+800
| +2% | +$53.3K | 0.01% | 409 |
|
|
2017
Q4 | $195K | Buy |
39,900
+14,900
| +60% | +$789K | 0.01% | 504 |
|
|
2017
Q3 | $106K | Buy |
+25,000
| New | +$999K | 0.01% | 570 |
|
|
2017
Q1 | – | Sell |
-18,700
| Closed | -$4K | – | 1234 |
|
|
2016
Q4 | $4K | Sell |
18,700
-59,400
| -76% | -$2.39M | ﹤0.01% | 908 |
|
|
2016
Q3 | $1.37M | Sell |
78,100
-297,300
| -79% | -$8.99M | 0.05% | 205 |
|
|
2016
Q2 | $1.09M | Buy |
375,400
+361,700
| +2,640% | +$6.7M | 0.06% | 212 |
|
|
2016
Q1 | $24K | Sell |
13,700
-56,100
| -80% | -$980K | ﹤0.01% | 608 |
|
|
2015
Q4 | $515K | Buy |
69,800
+59,400
| +571% | +$1.93M | 0.02% | 373 |
|
|
2015
Q3 | $17K | Buy |
+10,400
| New | +$353K | ﹤0.01% | 838 |
|
|
2014
Q3 | – | Sell |
-95,500
| Closed | -$67K | – | 1152 |
|
|
2014
Q2 | $67K | Buy |
+95,500
| New | +$3.02M | ﹤0.01% | 702 |
|
|
2014
Q1 | – | Sell |
-101,800
| Closed | -$468K | – | 1349 |
|
|
2013
Q4 | $468K | Buy |
101,800
+41,900
| +70% | +$1.25M | 0.01% | 589 |
|
|
2013
Q3 | $586K | Buy |
+59,900
| New | +$2.31M | 0.02% | 495 |
|
Other funds holding SRPT
EAM
HAP Trading's SRPT Position: Q3 2024 in Review
HAP Trading sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 41,077 shares — an estimated $6.49M sold.
HAP Trading first reported a position in SRPT in Q2 2013 and held it in 9 quarters. The position peaked at $7.67M in Q2 2019. 458 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.
- HAP Trading reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
- HAP Trading sold 41,077 Sarepta Therapeutics shares in Q3 2024, an estimated $6.49M.
- HAP Trading first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 9 quarters.
- HAP Trading's Sarepta Therapeutics position peaked at $7.67M in Q2 2019.
- 458 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.
Based on HAP Trading's 13F filing for Q3 2024, filed 12 Nov 2024.